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Introduction: The restrictive mitral valve annuloplasty (RMA) is the treatment of 
choice for degenerative mitral regurgitation (MR), but postoperative functional mitral 
stenosis remains a matter of debate. In this study, we sought to determine the impact 
of mitral stenosis on the functional capacity of patients.
Methods: In a cross- sectional study, 32 patients with degenerative MR who under-
went RMA using a complete ring were evaluated. All participants performed treadmill 
exercise test and underwent echocardiographic examinations before and after 
exercise.
Results: The patients’ mean age was 50.1 ± 12.5 years. After a mean follow- up of 
14.1 ± 5.9 months (6–32 months), the number of patients with a mitral valve peak 
gradient >7.5 mm Hg, a mitral valve mean gradient >3 mm Hg, and a pulmonary arte-
rial	pressure	(PAP)	≥25	mm	Hg	at	rest	were	50%,	40.6%,	and	62.5%,	respectively.	13	
patients	(40.6%)	had	incomplete	treadmill	exercise	test.	All	hemodynamic	parameters	
were higher at peak exercise compared with at rest levels (all P < .05). The PAP at rest 
and at peak exercise as well as peak transmitral gradient at peak exercise were higher 
in patients with incomplete exercise compared with complete exercise test (all P < .05). 
The	PAP	at	rest	(a	sensitivity	and	a	specificity	of	84.6%	and	52.6%,	respectively;	area	
under the curve [AUC] = .755) and at peak exercise (a sensitivity and a specificity of 
100%	and	47.4%,	respectively;	AUC	=	.755)	discriminated	incomplete	exercise	test.
Conclusion: The RMA for degenerative MR was associated with a functional stenosis 
and the PAP at rest and at peak exercise discriminated low exercise capacity.
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1  | INTRODUCTION
Mitral regurgitation (MR) is a common heart valve disease, which is 
mainly attributable to the degenerative/myxomatous mitral valve dis-
eases.1 The restrictive mitral valve annuloplasty (RMA) is the treat-
ment of choice for severe degenerative MR, and it is superior to the 
mitral valve replacement (MVR).2 The gold standard of treatment for 
secondary MR includes RMA or MVR; however, it is a topic of much 
debate.3 Based on the latest ACC/AHA guideline,4 the RMA is the 
class I recommendation for primary severe MR, while it has been re-
garded as class IIb for severe secondary MR. The major complication 
after RMA includes recurrent MR and mitral stenosis. The mechanism 
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and incidence of early or late functional mitral stenosis after the im-
plementation of RMA for patients with MR are poorly elucidated. The 
development of pannus overgrowth or using undersized ring for the 
RMA has been reported to be the main etiologies for the development 
of mitral stenosis after RMA.5 In previous studies, the functional mitral 
stenosis has been defined as a mean transmitral pressure gradient of 
>5 mm Hg or a mitral valve area (MVA) of <1.5 cm2 in patients with a 
functional MR secondary to either ischemic or idiopathic cardiomy-
opathy.6–14 In addition, a higher mitral valve gradient at rest and at 
peak exercise as an indicative of functional mitral stenosis has been 
found to be influenced by the type of annuloplasty in patients with 
degenerative MR.15,16
In this study, we sought to determine the prevalence of functional 
mitral stenosis in patients undergoing RMA with complete ring for 
myxomatous MR. In addition, we decided to evaluate the patients’ 
functional capacity and hemodynamic outcomes using the implemen-
tation of treadmill exercise test associated with an echocardiographic 
evaluation of mitral valve hemodynamics during exercise test. We also 
attempted to determine factors predicting reduced exercise capacity.
2  | MATERIALS AND METHODS
2.1 | Study protocol and population
In a cross- sectional study, patients who had undergone the RMA 
from January 2012 to December 2015 were recruited into the study. 
Demographic data as well as surgical and perioperative echocardio-
graphic parameters were retrospectively extracted from the patients’ 
medical records. All patients were older than 18 years, had myxoma-
tous mitral valve prolapse (MVP), and underwent the RMA using a com-
plete ring insertion. Exclusion criteria included severe MR caused by 
etiologies rather than myxomatous MVP, residual MR immediately after 
RMA greater than mild in severity, ischemic MR, atrial fibrillation, refuse 
to participate, and the inability to perform exercise test. Thereafter, 
all patients were examined using a transthoracic echocardiography 
(TTE) and an exercise test using Bruce protocol at the same day. This 
study was approved by the ethics committee of our institution, Rajaie 
Cardiovascular Medical and Research Center, Tehran, Iran. In addition, 
consent form was obtained from all participants before evaluation by 
an exercise test and a TTE test. All echocardiographic parameters were 
measured at rest and at peak exercise test to evaluate the functional 
capacity of patients and its effect on valve hemodynamics.
2.2 | RMA operative techniques
During the surgical repair of MVP, all patients underwent mid-sternotomy 
on- pump cardiac surgery. All procedures were performed by a single sur-
geon and his assistants. Annuloplasty sizing was similar and determined 
based on the size of the anterior leaflets; neither oversizing nor undersiz-
ing of annuloplasty ring was implemented in this cohort. The repair of 
anterior leaflet involvement was performed by a PTFE neochordal inser-
tion; the repair of posterior leaflet included either triangular resection 
or quadrangular resection with or without sliding plasty, and bileaflet 
involvement was repaired using a combination of the above- mentioned 
procedures. In addition, the commisurotomy was also used in some cases 
when required. A target mean mitral gradient <5 mm Hg or a mitral valve 
area	of	 ≥2.5	cm2 after repair was considered acceptable along with a 
minimal MR and a coaptation length of >5 mm.
2.3 | Treadmill exercise test
An ergometry treadmill exercise test using the Bruce protocol was 
performed, during which all patients exercised to exhaustion. They 
were asked to stop the use of calcium channel blocker or β- blockers 
at least 12–24 hours before the exercise test. An exercise capacity 
in metabolic equivalents of task (METs) was estimated according to 
the speed and grade achieved (1 MET equivalent to 3.5 mL/kg/min 
of oxygen consumption). Treadmill exercise test was performed ac-
cording to the AHA Guideline.17 The incomplete exercise test or low 
workload was defined as <7 METs for men and <5 METs for women.
2.4 | Echocardiographic assessment
The TTE examination was performed by a single echocardiographer using 
a Vivid 3 ultrasound system (GE Medical System, Horton, Norway) and a 
1.7/3.4 MHz transducer. A two- dimensional (2D) electrocardiogram was 
superimposed on the images. All patients underwent echocardiography 
at 2 steps, at rest and at peak exercise test. Postexercise echocardio-
graphic images were acquired within 1 minute after peak exercise test. 
All echocardiographic measurements were performed using the proto-
cols and the standards of the latest guidelines for native valve disease.18
The left ventricle ejection fraction was evaluated using a mod-
ified biplane Simpson method. The TMG were calculated based on 
the modified Bernoulli equation. The MVA was measured using 2D 
planimetry in the parasternal short- axis view at valve tips. The pres-
sure half- time (PHT) was calculated as the interval between the max-
imum mitral gradient in early diastole and the time point where the 
gradient is half the maximum initial value (ms). The effective orifice 
area (EOA) was calculated by the continuity equation as the stroke 
volume measured in the left ventricle outflow tract divided by the 
integral of the transmitral velocity during diastole. Indexed EOA was 
also calculated as EOA divided by body surface area. The anterior and 
posterior leaflet opening angles (ALOAs and PLOAs) were measured 
in four- chamber view according to the following formulas: 
 
in which the BD is the bending distance, the ABLD is the anterior leaf-
let bending distance, the CD is the coaptation length, and the PLL is 
the posterior leaflet length.
The right ventricle function was evaluated using visual assess-
ment by 2 expert echocardiographists concomitant with the following 
criteria:
(1)ALOA = sin−1
(
BD
ALBD
)
(2)PLOA = sin−1
(
CD
PLL
)
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1. S > 10 m/s defined as normal right ventricle function
2. S = 9–10 m/s defined as mild right ventricle dysfunction
3. S = 9–7 m/s defined as moderate right ventricle dysfunction
4. S < 7 m/s defined as severe right ventricle dysfunction,
in which “S” was systolic velocity in the right ventricle measured by tissue 
Doppler imaging.
2.5 | Statistical analysis
Categorical variables are presented as numbers (percentages). 
Normally distributed quantitative variables were presented as 
mean ± standard deviation, and those nonnormally distributed are 
presented as median (interquartile range). The continuous variables 
at pre- and postexercise tests were analyzed using a paired t test. The 
changes in categorical variables at time intervals were analyzed using 
Friedman test. Correlation between variables was evaluated using 
Pearson correlation coefficient. Receiver operating characteristics 
curve was constructed. Logistic regression analysis was used to iden-
tify the predictors of incomplete exercise test. Two- sided P- values 
were calculated. All analyses were performed using SPSS statistical 
software, version 21.0 (IBM Corp, Armonk, NY, USA).
3  | RESULTS
3.1 | Patients’ characteristics
Of 38 patients who met our inclusion criteria, only 32 cases were 
entered in final analysis. Six cases were excluded as follows: (1) a 
31-	year-	old	 female	 patient	 (2.6%)	who	 had	 atrial	 fibrillation	with	 a	
rapid	ventricular	response,	(2)	a	33-	year-	old	male	patient	(2.6%)	who	
completed the exercise test, but he was found to have a partial rup-
ture of surgical annuloplasty ring, which created 2 transmitral flows 
during the TTE examination (he underwent reoperation due to ring 
dehiscence),	and	(3)	4	cases	(10.5%)	with	a	moderate	or	severe	MR	at	
the time of study.
Finally, 32 cases undergoing the RMA with a complete ring inser-
tion were evaluated. The patients’ mean age was 50.1 ± 12.5 years, 
and	most	of	 them	was	male	 (23	patients,	71.9%).	A	semirigid	annu-
loplasty	ring	was	used	in	87.5%	of	patients,	and	46.9%	of	them	had	
concomitant	 operations.	 A	 total	 of	 15	 patients	 (46.9%)	 underwent	
concomitant operations, including 5 cases of coronary artery bypass 
graft surgery, 4 cases of closure of patent foramen ovale, 2 cases of 
closure of ventricular septal defect, 2 cases of closure of atrial sep-
tal defect, and 2 cases of left atrial appendage closure. Most of cases 
had	functional	class	II	or	III	before	operation	(46.9%	and	25%,	respec-
tively). The mitral valve mean gradient, mitral valve peak gradient, the 
EOA, and the PAP at rest were 3.3 ± 1.8 mm Hg, 7.9 ± 3.7 mm Hg, 
1.9 ± 0.6, and 26.1 ± 6.3 mm Hg, respectively. Other characteristics 
and surgical factors are summarized in Table 1.
All patients were followed up during a mean of 14.1 ± 5.9 months 
(6–32	months).	The	majority	of	patients	(59.4%)	had	functional	class	I	
at	immediate	postoperative	time,	and	68.8%	of	patients	had	functional	
TABLE  1 Baseline characteristics, echocardiographic features, 
and surgery- related factors in patients undergoing mitral 
annuloplasty
Study variables Values
Number of patients 32
Age, y 50.1 ± 12.5
Body surface area, kg/m2 1.8 ± 0.2
Sex (male/female) 23	(71.9%)/9	(28.1%)
NYHA functional class
Class I 6	(18.8%)
Class II 15	(46.9%)
Class III 8	(25%)
Class IV 3	(9.4%)
Preoperative echocardiographic features
LVEF,	% 52.7 ± 6.2
TAPSE, mm 17.6 ± 2.2
PAP, mm Hg 32.2 ± 11.9
Involved mitral valve leaflets
Anterior 4	(12.5%)
Posterior 17	(53.1%)
Bileaflet 11	(34.4%)
Right ventricular dysfunction
No dysfunction 20	(62.5%)
Mild dysfunction 9	(28.1%)
Moderate dysfunction 3	(9.4%)
Surgery- related factors
CPB time, min 110.3 ± 33
Co- operations 15	(46.9%)
Triangular resection 10	(31.2%)
Quadrangular resection 5	(15.6%)
Neochordae 9	(28.2%)
Other 8	(25%)
Ring size 30.5 ± 2.9
Ring type
Semirigid 28	(87.5%)
Flexible 3	(9.4%)
Rigid 1	(3.1%)
Ring brand
3D MEMO 14	(43.8%)
CG future 7	(21.9%)
Physio 1	(3.1%)
Segiun 6	(18.8%)
Tailor 2	(6.2%)
Duran 1	(3.1%)
Carpentier 1	(3.1%)
NYHA = New York Heart Association; LVEF = left ventricular ejection 
fraction; TAPSE = tricuspid annular plane systolic excursion; PAP = pulmo-
nary arterial pressure; CPB = cardiopulmonary bypass.
Data are presented as mean ± SD or number (percentage).
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class I at last follow- up. When we compared changes in functional 
class from preoperative to last follow- up, there was a significant dif-
ference (P < .001). When categorized the hemodynamics into high and 
low levels based on previous studies15,19 or the median values in our 
patients, the number of patients with a mitral valve peak gradient of 
>7.5 mm Hg, a mitral valve mean gradient of >3 mm Hg, and the PAP 
≥25	mm	Hg	at	rest	were	50%,	40.6%,	and	62.5%,	respectively.
3.2 | Treadmill exercise stress echocardiography
All patients were examined using a treadmill exercise test. Thirteen 
patients	 (40.6%)	had	an	 incomplete	 exercise	 test.	 The	achieved	ex-
ercise capacity was 9.02 ± 2.26 METs, and it was 6.6 ± 0.9 METs in 
patients with an incomplete test. All echocardiography parameters 
evaluating the mitral valve hemodynamics were assessed before and 
after exercise test. All hemodynamic parameters were significantly 
higher at peak exercise test compared with those at rest (Table 2).
Correlation between echocardiographic parameters and hemody-
namic parameters and achieved METs was also evaluated. There was 
a trend toward patients with higher levels of peak gradient at rest and 
at peak exercise test to have lower amounts of EOA at rest. There was 
significant inverse correlation between peak gradient at peak exercise 
and the EOA at peak exercise (P = .041). In addition, there was a trend 
toward patients with higher levels of transmitral peak gradient at peak 
exercise and a transmitral mean gradient at peak exercise to have lower 
amounts of EOA at exercise test. There was significant inverse correla-
tion between PAP at rest and at peak exercise test and achieved METs 
(P = .006 and P = .032, respectively). Transmitral peak gradient at peak 
exercise was also inversely correlated with achieved METs (r	=	−.351,	
P = .049). Other correlations are summarized in Table 3.
All patients were also categorized into 2 groups based on the ex-
ercise capacity, high workload or complete exercise test group (ie, pa-
tients with METs >7) and low workload or incomplete exercise test 
group (ie, patients with METs <7). The PAP at rest and at peak exercise 
tests were significantly higher in patients with incomplete exercise com-
pared with complete exercise group (28.9 ± 7.2 vs 23.6 ± 4.7 mm Hg, 
P = .018 and 32.2 ± 7.4 vs 38.9 ± 11.2 mm Hg, P = .050, respectively). 
In addition, the peak transmitral gradient at peak exercise was also sig-
nificantly higher in patients with incomplete exercise compared with 
complete exercise group (20 ± 7.7 vs 14.5 ± 5.5 mm Hg, P = .024). 
Other variables are summarized in Table 4.
3.3 | ROC analysis
ROC curve analysis was used to detect echocardiographic parameters 
(ie, mitral valve hemodynamic features) in discriminating patients with 
an	incomplete	exercise	test.	The	PAP	at	rest	of	≥22.5	mm	Hg	(sensi-
tivity	and	a	specificity	of	84.6%	and	52.6%)	and	the	PAP	at	peak	ex-
ercise	of	≥29	mm	Hg	(sensitivity	and	a	specificity	of	100%	and	47.4%)	
discriminated low workload test. The area under the curve (AUC) for 
the PAP at rest and at peak exercise was .755 and .717, respectively. 
The results of other values in ROC curve analyses were summarized 
in Table S1. We excluded patients with moderate RV dysfunction and 
recalculated the discriminatory role of PAP in our cohort. The AUC 
for the PAP at rest and at peak exercise was .798 (cutoff = 27.5; a 
sensitivity	and	a	specificity	of	72%	and	73%)	and	.763	(cutoff	=	29;	a	
sensitivity	and	a	specificity	of	100%	and	50%),	respectively.
4  | DISCUSSION
In this study, we showed that patients undergoing RMA using a com-
plete prosthetic ring for the repair of myxomatous MVP might have 
some degrees of deteriorated mitral valve hemodynamics and in-
creased levels of PAP during follow- up period. These hemodynamic 
parameters increased more after treadmill exercise test compared 
with at rest, suggesting the development of functional mitral stenosis 
and a consequent less exercise capacity. Moreover, the PAP at rest 
and peak exercise as well as transmitral peak gradient at peak exercise 
correlated with lower exercise capacity, and the PAP at rest and peak 
exercise discriminated patients with lower exercise capacity; how-
ever, mitral valve hemodynamic parameters did not.
Although RMA is considered the treatment of choice in patients 
with degenerative MR, it is associated with an impairment of valve 
hemodynamics. During an RMA procedure, some components of mi-
tral valve are resected, which can lead to an abnormal coaptation, 
MR, and the remodeling of the mitral annulus.20 The main sequel of 
the RMA includes increased transmitral gradient and a subsequent 
functional mitral stenosis, which is similar to prosthesis- patient mis-
match developed after mitral valve replacement with a small pros-
thetic valve.15 It may be hypothesized that the consequences of RMA 
differ between patients with secondary or degenerative MR, as a 
complete and properly  sized prosthetic ring is usually implemented 
during the repair of degenerative MR, while the prosthetic ring is un-
dersized by 1 or 2 size in ischemic MR.7,15 The use of undersized ring 
along with a leaflet resection may reduce the mitral valve area and 
reduce valve opening, leading to valve obstruction.7,9–11,14 After RMA 
using complete ring in degenerative MR, the extensive resection of 
leaflets and using complete ring may also cause the development of 
functional mitral stenosis. In addition, the insertion of ring leads to 
TABLE  2 Hemodynamic and echocardiographic parameters 
before and after exercise echocardiography
At rest At peak exercise P
Heart rate 61.7 ± 5 161.5 ± 8.8 <.001
SBP 122.6 ± 6.9 152.6 ± 12.7 <.001
Stroke volume 63.5 ± 18.5 77.1 ± 22 <.001
Ejection fraction 45.6 ± 5.9 54.8 ± 7.2 <.001
PAP 25.8 ± 6.3 35 ± 9.6 <.001
Peak gradient 8 ± 3.7 16.7 ± 7 <.001
Mean gradient 3.4 ± 1.8 9.2 ± 4.4 <.001
EOA 1.9 ± 0.6 2.2 ± 0.8 .003
SBP = systolic blood pressure; PAP = pulmonary artery pressure; EOA = 
effective orifice area.
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changes in annular dimension and consequently involves the expan-
sion of valve annulus during cardiac cycle.21 Given these hypotheses 
and the use of incomplete ring or band during recent era of RMA 
operations for degenerative MR,15 it seems that further studies with 
more attention on the type of prosthetic ring or band and the amount 
of leaflet resection as well as using three- dimensional echocardiogra-
phy might provide valuable data regarding the underlying mechanism 
of this phenomenon.
Chan et al. reported that following RMA for degenerative MR, 
it is more likely to observe elevated mitral gradients, worse hemo-
dynamics, a lower exercise capacity, and a higher PAP level, both at 
rest and at peak exercise test. They concluded that refinement in 
the RMA techniques might reduce transmitral gradient impairment 
and consequent functional deterioration.15 Mesana et al.16 also 
studied patients with degenerative MR who underwent the RMA. 
They found that RMA using a complete ring may be associated with 
a higher transmitral gradient at rest and at peak exercise, which un-
derscores the careful consideration of annuloplasty type and size at 
the time operation. Bertrand et al.7 evaluated the effect of mitral 
stenosis after RMA in patients with secondary MR, mainly ischemic 
one. They showed that EOA increases during exercise, and diastolic 
anterior leaflet tethering played a key role in this dynamic process. In 
addition, indexed EOA at peak exercise was an independent predic-
tor of exercise capacity and was associated with clinical outcomes. 
In contrast, in a group of patients with ischemic MR undergoing the 
RMA, transmitral gradient was not associated with functional ca-
pacity and it should be considered as a measurement of patients’ 
hemodynamics.6 Our findings are in lines with these studies too. We 
found that approximately half of patients had at least mild functional 
mitral stenosis at modest follow- up period. Moreover, all these 
 hemodynamic parameters significantly  deteriorated after treadmill 
exercise test.
Alteration in the transmitral gradients after RMA is associated 
with physiological and functional impacts on patients’ outcomes. 
The increased level of transmitral gradient after the RMA operation 
is associated with elevated levels of B- type natriuretic peptide.15 
It has been also demonstrated that mitral stenosis can lead to ele-
vated intracardiac pressures, particularly left atrial pressures which 
can consequently increase PAP.19 So, the increment of PAP after 
the RMA represents a substantial physiological response to func-
tional mitral stenosis which may or not influence functional capac-
ity. Several studies reported that PAP may be better indicative of 
decreased exercise capacity than mitral valve gradients in patients 
undergoing the RMA. Kainuma et al.9 demonstrated that RMA for 
functional MR resulted in functional mitral stenosis, some degrees 
of mitral obstruction, higher transmitral gradients, and a lesser value 
of EOA. However, their findings were somewhat more suggesting 
residual pulmonary hypertension as the most important sequel of 
RMA, rather than functional mitral stenosis. Magne et al.11 showed 
that among patients with ischemic MR undergoing RMA, the func-
tional mitral stenosis was associated with a higher PAP and a worse 
functional capacity. In the present study, we found that the stron-
gest factors for discriminating exercise capacity included the PAP at 
rest and at peak exercise. It remains to be determined to what ex-
tent the level of these hemodynamic impairments influences clinical 
outcomes of these patients. The easily measured PAP can be used 
for the surgical management of patients if we examine this value in 
patients with different mitral valve pathologies and different surgical 
TABLE  3 Correlation between echocardiographic and hemodynamic parameters and achieved METs
EOA at rest EOA at peak exercise Achieved METs
Correlation coefficient P Correlation coefficient P Correlation coefficient P
Heart rate at rest .013 .944 −.001 .997 −.141 .442
Heart rate at peak exercise −.045 .808 .019 .918 −.184 .312
SBP at rest −.026 .921 −.192 .461 −.206 .429
SBP at peak exercise −.072 .783 −.163 .531 −.033 .899
Peak gradient at rest −.346 .052 −.349 .050 −.149 .414
Peak gradient at peak exercise −.328 .066 −.363 .041 −.351 .049
Mean gradient at rest −.247 .172 −.326 .068 .097 .596
Mean gradient at peak exercise −.229 .207 −.278 .123 .191 .296
PAP at rest .061 .739 .057 .758 −.478 .006
PAP at peak exercise .076 .678 .165 .368 −.380 .032
Stroke volume at rest .339 .057 .362 .042 .207 .255
Stroke volume at peak exercise .326 .069 .477 .006 .094 .610
LVEF at rest .244 .179 .198 .278 .170 .352
LVEF at peak exercise .226 .214 .217 .233 .145 .428
Achieved METs .244 .179 .153 .403 — —
EOA = effective orifice area; SBP = systolic blood pressure; PAP = pulmonary artery pressure; LVEF = left ventricular ejection fraction; MET = metabolic 
equivalents of task.
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approaches. Moreover, the evaluation of PAP before RMA can also 
provide important index for the risk stratification of patients and 
probable modifications in the surgical management of such cases. 
Further large- scaled studies are required to show the applicability of 
PAP in patients undergoing RMA operation.
4.1 | Study limitations
When interpreting our results, you should consider some shortcom-
ings. First, this is a retrospective evaluation of relatively small group of 
patients. Second, our findings cannot be applicable to other centers, 
particularly due to different techniques used for RMA. Third, we only 
included patients being able to perform exercise test and those may 
be more mild or moderate grades of functional stenosis such that pa-
tients with severe forms had been excluded from our cohort. Fourth, 
we have included patients with moderate right ventricular dysfunc-
tion, which can influence the measurement of PAP; however, when 
we excluded 3 patients with moderate right ventricular dysfunction, 
there was a little difference in the accuracy of PAP at rest and at peak 
exercise in discriminating patients with incomplete exercise test. 
Finally, our follow- up was relatively short and we did not have clinical 
outcomes of patients to explore more aspects of patients’ functional 
outcome.
5  | CONCLUSION
The implementation of RMA with complete prosthetic ring in pa-
tients with degenerative MR is associated with impaired transmitral 
gradients, increased PAP, and lower exercise capacity. These hemo-
dynamic parameters more deteriorated after exercise test despite 
fixed annular ring. Moreover, elevated PAP at rest and at peak exer-
cise and peak transmitral gradient at peak exercise were associated 
with lower exercise capacity. Our findings emphasize on the modifi-
cation of RMA operations in degenerative MR to improve outcomes 
of patients.
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